Biomedical subjects

Nobuyuki Koga

Publications and source records attributed to Nobuyuki Koga.

8 recordsLinked to original sources

PubMed2006

Molecular-based haplotype analysis of the beta 2-adrenergic receptor gene (ADRB2) in Japanese asthmatic and non-asthmatic subjects.

BACKGROUND: The beta2-adrenergic receptor gene (ADRB2) is a target molecule of beta2-agonists. Single nucleotide polymorphisms (SNPs) in the ADRB2 are related to the effectiveness of beta2-agonists. However, there are some discrepancies in the results of pharmacogenetic studies of ADRB2 among different ethnic groups. The aims of this study were to determine the ADRB2 haplotypes and diplotypes in Japanese asthmatic and non-asthmatic subjects and to examine their relation to asthma and to compare these results with previous studies done in other ethnic groups. METHODS: Complete sequences for 3 kb promoter and 1.2 kb structural regions of ADRB2 were analyzed in 48 Japanese asthmatics and 100 controls, and haplotypes and diplotypes of SNPs were analyzed. RESULTS: Fifteen SNPs including a novel one in -839 were observed. Allele frequencies for all SNPs were similar between asthmatics and controls. We also identified 42 haplotypes and 54 diplotypes of ADRB2 in a Japanese population. The frequencies were similar between the two groups. They were classified into 17 and 23 types, respectively, according to Drysdale's haplotype-organization system, and a significant ethnic difference was observed between the Japanese and Caucasian populations. CONCLUSIONS: The frequencies of SNPs and ADBR2 haplotypes in Japanese are different from those in Caucasians and African Americans. These divergences might imply the need for independent pharmacogenetic studies for ADBR2 in each ethnic group.

Black or African American↗

PubMed2005

The decrease in level of serum thyroxine by 2,2',4,5,5'-pentachlorobiphenyl in rats and mice: no correlation with formation of methylsulfonyl metabolites.

A relationship between formation of methylsulfonyl (MeSO2) metabolites of 2,2',4,5,5'-pentachlorobiphenyl (PentaCB) and decrease in serum thyroxine (T4) level was examined in the rats and mice after a single i.p. injection of PentaCB (342 micromol/kg body weight). In either rats or mice, levels of the 3- and 4-MeSO2 metabolites of PentaCB in the liver and feces increased in a time-dependent fashion up to 8 days after PentaCB-treatment. However, there was a marked difference between rats and mice in the amount of the metabolites formed, and the cumulative amount of the either MeSO2 metabolite for 8 days after PentaCB treatment in the liver was 4 to 15 times higher in mice than in rats. On the other hand, a 40 to 60% decrease in level of serum total T4 occurred in both rats and mice at 1 day after PentaCB treatment, and the decrease was retained up to 8 days after PentaCB treatment. Thus, there was a marked difference between rats and mice in the formation of MeSO2 metabolites from PentaCB but not a significant difference between rats and mice in PentaCB-induced decrease in the level of serum total T4, indicating that PentaCB-induced decrease in the level of serum total T4 is not necessarily dependent on the MeSO2 metabolites formed.

Animals↗

PubMed2005

[Metabolism of 2, 3', 4, 4', 5-pentachlorobiphenyl in guinea pig microsomes].

The in vitro metabolism of 2,3',4,4',5-pentachlorobiphenyl (pentaCB) (CB118) was studied using liver microsomes of guinea pigs and the effect of cytochrome P450 inducers, phenobarbital (PB) and 3-methylcholanthrene (MC) on CB118 metabolism was also compared. After 30 min-incubation at 37 degrees C with liver microsomes of guinea pigs, CB118 was hydroxylated to two metabolites (M(-1) and M(-2)) with retention times of 15.84 min and 20.01 min in GC/ECD, respectively. GC/MS showed that the methylated derivative of a major metabolite M(-2) had the molecular weight of 354 and an intense fragment ion of [M(+)-50] which is a characteristic ion for PCBs possessing a methoxy-group at the 2 (2')- or the 6 (6')-position. By comparison of the mass fragmentation and the retention times in GC/MS with the synthetic authentic compounds, M(-2) was identified as 2-hydroxy-3,3',4,4',5-pentaCB (CB126). On the other hand, the methylated derivative of a minor metabolite M(-1) had the molecular weight of 320 and the similar fragment ion of [M(+)-50] to the methylated M(-2), assuming that M(-1) was a dechlorinated monohydroxy-tetrachlorobiphenyl (tetraCB) possessing hydroxy-group at the 2 (2')- or the 6 (6')-position. However, the precise structure of M-1 could not be determined because its retention time in GC was in disagreement with that of the candidate 6-hydroxy-3,3',4,4'-tetraCB. PB-treatment increased the formation of M(-1) and M(-2) to 2.2- and 6.8-fold of untreated animals, whereas MC-treatment increased only M(-2) to 2.6-fold of untreated ones. Addition of antiserum against a PB-inducible guinea pig cytochrome P450, CYP2B18, completely inhibited the formation of M(-2). These results suggest that CB118 is principally metabolized by CYP2B18 to 2-hydroxy-CB126 which is formed via a 2,3-epoxide intermediate and the subsequent NIH-shift of a chlorine at the 2-position to the 3-position in guinea pig liver.

Animals↗

PubMed2004

Comparative metabolism of polychlorinated biphenyls and tissue distribution of persistent metabolites in rats, hamsters, and Guinea pigs.

The present study was performed to compare the metabolite profiles of polychlorinated biphenyls (PCBs) in the liver and serum of rats, hamsters, and guinea pigs after exposure to a PCB mixture, Kanechlor 500 (100 mg/kg, i.p.). The percentage of contribution of major PCB residues in the liver 5 days after exposure indicated that nonplanar PCBs with 2,4- or 2,3,4-chlorine substitution were more abundant in the liver in the order rats (43% of total PCBs) > hamsters (20%) > guinea pigs (11%), whereas coplanar PCBs with 4-, 3,4-, or 3,4,5-chlorine substitution were predominant in guinea pigs (61%), followed by hamsters and rats (both 26%). The hepatic concentrations of methylsulfonyl metabolites (MeSO(2)-CBs) were higher in the order guinea pigs > rats > hamsters. Whereas hamsters formed minute amounts of MeSO(2)-CBs from 2,5-dichloro-substituted PCBs, guinea pigs formed higher levels of meta-MeSO(2)-CBs derived from 2,3,6-trichloro-substituted PCBs. In contrast, the serum concentrations of phenolic PCBs were higher in the order hamsters > rats > guinea pigs. Metabolites were predominated by 4-OH-2,3,5,3',4'-pentaCB (89% contribution) for rats, 3-OH-2,4,5,2',4'-pentaCB (56%) for guinea pigs, and dihydroxylated metabolites (39%) for hamsters. The reduced elimination of coplanar PCBs and the specific distribution of MeSO(2)- and phenolic PCBs may have implications for the differences in sensitivity to PCB toxicity among rats, guinea pigs, and hamsters.

Animals↗

PubMed2004

Metabolism of polychlorinated biphenyls by Gunn rats: identification and serum retention of catechol metabolites.

The tissue distributions of persistent metabolites of polychlorinated biphenyls (PCBs) in Wistar rats and homozygous uridine diphosphate glucuronosyltransferase (UGT) deficient Gunn rats exposed to 2,4,5,2',5'-pentachlorobiphenyl (CB101) and the commercial PCB mixture, Kanechlor-500 (KC500), were investigated. After exposure to CB101, four hydroxy and two methylsulfonyl (MeSO2) metabolites were detected in liver, lung, kidney, blood, and adipose tissues. One was identified as 3',4'-(OH)2-2,4,5,2',5'-pentaCB, which was retained selectively in the serum of Gunn rats. Comparative analysis of the metabolite profiles in both rat strains after exposure to KC500 showed higher formation ratios of several dihydroxy PCB metabolites in the liver of Gunn rats; major metabolites are the catechols from 2,5,3',4'-tetraCB, CB101, 2,3,6,3',4'-pentaCB, and 2,3,6,2',4',5'-pentaCB. Thus, Gunn rats effectively metabolized PCBs with 2,5- or 2,5,6-chlorine substitution to the 3,4-catechol, but less formed MeSO2 metabolites in the liver. Although both rat strains retained 4-OH-2,3,5,3',4'-pentaCB in serum, Gunn rats also retained the catechol PCBs, accounting for about 52% of the total phenolic PCBs. These results suggest that a lack of UGTs markedly alters the formation ratios and retention profiles of catechols and MeSO2 metabolites of PCBs.

Animals↗

PubMed2004

Reduction of the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in mice using an antiulcer drug, geranylgeranylacetone.

The protective effect of geranylgeranylacetone (GGA), an antiulcer drug, against the acute toxicity and teratogenicity produced by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) was examined in C57BL/6J mice. When mice were co-treated, GGA reduced the loss of body weight gain and lethality produced by TCDD but hepatomegaly and thymic atrophy were not improved. Additionally, no protective effect of GGA was observed in the formation of cleft palate and hydronephrosis in mouse fetuses caused by maternal exposure to TCDD. To clarify the reducing mechanism by GGA, the Hsp70.1 mRNA levels in liver and intestine were analyzed. However, it was difficult to explain the effect of GGA from the induction of Hsp70.1. GGA had also no effect on the induction of hepatic ethoxyresorufin O-deethylase activity by TCDD. These data suggest that GGA exhibits a protective effect against some forms of dioxin toxicity by a mechanism without involving inhibition of arylhydrocarbon receptor activation.

Abnormalities, Drug-Induced↗

PubMed2003

Effects of polychlorinated biphenyls, kanechlor-500, on serum thyroid hormone levels in rats and mice.

Effects of a commercial polychlorinated biphenyls mixture, Kanechlor-500 (KC500), on the levels of serum thyroid hormones such as total thyroxine (T4) and triiodothyronine (T3) were examined comparatively in male Wistar rats and ddy mice. Serum T4 levels were significantly decreased in both rats and mice 4 days after a single ip injection of KC500 (100 mg/kg body weight), whereas decreased levels of T3 were observed in mice but not in rats. In addition, no significant change in the level of serum thyroid stimulating hormone was observed in either rats or mice. Hepatic UDP-glucuronosyltransferases (UDP-GTs) UGT1A1 and UGT1A6, which efficiently mediate glucuronidation of T4 and promote the excretion of the hormones, were induced by KC500 in rats but not in mice. Hepatic microsomal cytochrome P450 (P450) content and the microsomal activity for 7-ethoxy-, 7-pentoxy-, and 7-benzoyloxy-resorufin dealkylations were significantly increased by KC500 in both rats and mice, although the magnitude of increase in the enzyme activities was higher in rats than in mice. The difference in the increase in the activity of microsomal enzymes, including UDP-GT and P450, between KC500-treated rats and mice was not correlated with that in the level of hepatic methylsulfonyl-PCB metabolites. In the present study, we found for the first time that the decrease in serum T4 levels by KC-500 in mice occurred without increase in hepatic UDP-GTs, UGT1A1 and UGT1A6, responsible for T4 glucuronidation. The present findings further suggested that although the decrease in serum T4 levels in KC500-treated rats would occur at least in part through the induction of the UDP-GTs, it might not be dependent on only the increase in the enzymes.

Animals↗

PubMed2003

[Metabolism of 2,3,3',4,4'-pentachlorobiphenyl in hamsters].

The in vivo metabolism of 2,3,3',4,4'-pentachlorobiphenyl (CB105) was studied in hamsters and the effect of cytochrome P450 inducers, phenobarbital (PB) and 3-methylcholanthrene (MC) on its metabolism was compared to rats. After administration of CB105 intraperitoneally at a dose of 3 mg/body, four metabolites, named M-1, M-2, M-3 and M-4, were detected in 5 days-feces of all groups and the formation ratio of the metabolites M-1-M-4 was 1:39:84:0.2 in untreated hamsters and 1:19:6.7:0.7 in untreated rats. On the basis of the mass spectra of four synthetic authentic compounds and the retention times on DB-1 and MPS50 columns, M-1, M-2, M-3 and M-4 were identified as 4'-hydroxy-2,3,3',4,5'-PenCB, 5'-hydroxy-CB105, 5-hydroxy-CB105 and 4-hydroxy-2,3,3',4',5-PenCB, respectively. The pretreatment of PB and MC resulted in about 2-fold fecal excretion of four metabolites in hamsters and in about 3-fold in rats. Of four metabolites, only M-4 were detected in the serum at 5 days after CB105 administration and the concentration was 0.39 microgram/ml of hamster serum and 0.28 microgram/ml of rat serum. In hamsters, the concentration of M-4 was increased to 1.8-fold of untreated animals by PB treatment and 2.6-fold by MC treatment. On the other hand, the treatment of rats with PB and MC did not show such an increase of serum M-4. These results suggested that the hamster oxidized 2,3,4-trichloro-substituted benzene ring predominantly rather than 3',4'-dichloro-substituted benzene ring differently from the rat and that M-4 formed in hamster liver distributed to the blood and retained there to a considerable extent in comparison with that formed in rat liver.

Animals↗